Sign in

CIK 0001420720

  • Non-accelerated filer
  • Smaller reporting company
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
262797813
Phone
+1 302-355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-07 Maddux Randy Joe Chief Operating Officer Sale −37,243 $0.68 $25K 271,757
2021-09-23 Isett Thomas Francis 3rd CEO and Executive Chairman Grant or award · Stock Option (right to buy) +2,000,000 2,000,000
2021-08-23 Lutz Robert Matthew See Remarks Grant or award · Stock Option (right to buy) +500,000 500,000
2021-08-23 Maddux Randy Joe Chief Operating Officer Grant or award · Stock Option (right to buy) +500,000 500,000
2021-08-23 Brenner Martin Chief Scientific Officer Grant or award · Stock Option (right to buy) +700,000 700,000
2021-08-23 Isett Thomas Francis 3rd CEO and Executive Chairman Grant or award · Stock Option (right to buy) +2,000,000 2,000,000
2021-08-23 Clark William D Director Grant or award · Stock Option (right to buy) +100,000 100,000
2021-06-07 Schimmelpennink Evert B. Director Grant or award · Stock Option +100,000 100,000
2021-04-30 Isett Thomas Francis 3rd CEO and Executive Chairman Grant or award · Stock Option (right to buy) +3,000,000 $1.37 $4.1M 3,000,000
2021-03-04 Lutz Robert Matthew See Remarks Grant or award +232,000 232,000
2021-03-04 Lutz Robert Matthew See Remarks Grant or award · Stock Option (right to buy) +350,000 350,000
2021-01-18 Brenner Martin Chief Scientific Officer Grant or award · Stock Option +500,000 500,000
2020-12-01 Maddux Randy Joe Chief Operating Officer Grant or award +309,000 309,000
2020-12-01 Maddux Randy Joe Chief Operating Officer Grant or award · Stock Option +465,000 465,000
2020-10-14 Armstrong Linda Washington Director Grant or award · Stock Option +100,000 100,000
2020-10-14 Kropotova Alexandra Director Grant or award · Stock Option +100,000 100,000
2020-10-14 Sender Gary Director Grant or award · Stock Option +100,000 100,000
2020-08-11 Eastern Capital LTD 10% owner Sale −15,864,436 $2.92 $46.3M 8,629,693
2020-08-10 Eastern Capital LTD 10% owner Sale −7,264,864 $3.91 $28.4M 24,494,129
2020-08-07 Eastern Capital LTD 10% owner Conversion +28,925,000 $0.20 $5.8M 33,114,597

Page 5 of 7 · 126 trades